Treatment-related neuroendocrine prostate cancer managed with partial stereotactic ablative radiotherapy (P-SABR) for long-term survival: a case series

BACKGROUND: The amount of treatment-related neuroendocrine prostate cancer (t-NEPC) increases after hormonal therapy, especially novel androgen receptor pathway inhibitors (ARPIs). T-NEPC is considered a hormone refractory [androgen receptor (AR)-negative] subtype of prostate cancer. Although tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Xin, Zhang, Zhuo-Fei, Gao, Xian-Shu, Qin, Shang-Bin, Bai, Yun, Yu, Wei, He, Qun, Fan, Yu, Zhang, Jian-Hua, Jiang, Yuan, He, Zhi-Song, Li, Hong-Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906108/
https://www.ncbi.nlm.nih.gov/pubmed/36760876
http://dx.doi.org/10.21037/tau-22-867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906108/
https://www.ncbi.nlm.nih.gov/pubmed/36760876
http://dx.doi.org/10.21037/tau-22-867

Ejemplares similares